GB0423950D0 - Pharmaceutical composition containing botulinum neurotoxin - Google Patents
Pharmaceutical composition containing botulinum neurotoxinInfo
- Publication number
- GB0423950D0 GB0423950D0 GBGB0423950.5A GB0423950A GB0423950D0 GB 0423950 D0 GB0423950 D0 GB 0423950D0 GB 0423950 A GB0423950 A GB 0423950A GB 0423950 D0 GB0423950 D0 GB 0423950D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical composition
- composition containing
- botulinum neurotoxin
- containing botulinum
- neurotoxin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A61K38/4893—Botulinum neurotoxin (3.4.24.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A61K2201/06—
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0423950A GB2426702A (en) | 2004-10-28 | 2004-10-28 | Pharmaceutical composition comprising botulinum neurotoxin |
US11/659,449 US20080102090A1 (en) | 2004-08-04 | 2005-08-03 | Pharmaceutical Compositon Containing Botulinum Neurotoxin A2 |
ES05767945.8T ES2526913T3 (en) | 2004-08-04 | 2005-08-03 | Pharmaceutical composition containing botulinum neurotoxin 2 |
EP05767945.8A EP1778279B1 (en) | 2004-08-04 | 2005-08-03 | Pharmaceutical composition containing botulinum neurotoxin a2 |
PCT/GB2005/003057 WO2006013370A1 (en) | 2004-08-04 | 2005-08-03 | Pharmaceutical composition containing botulinum neurotoxin a2 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0423950A GB2426702A (en) | 2004-10-28 | 2004-10-28 | Pharmaceutical composition comprising botulinum neurotoxin |
Publications (2)
Publication Number | Publication Date |
---|---|
GB0423950D0 true GB0423950D0 (en) | 2004-12-01 |
GB2426702A GB2426702A (en) | 2006-12-06 |
Family
ID=33515710
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0423950A Withdrawn GB2426702A (en) | 2004-08-04 | 2004-10-28 | Pharmaceutical composition comprising botulinum neurotoxin |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2426702A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2072039A1 (en) * | 2007-12-21 | 2009-06-24 | Merz Pharma GmbH & Co.KGaA | Use of a neurotoxic component of Clostridium botulinum toxin complex to reduce or prevent side effects |
EP3612154A4 (en) * | 2017-04-20 | 2020-12-16 | Bonti, Inc. | Botulinum neurotoxins for treating hyperhidrosis |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030095927A1 (en) * | 1997-10-01 | 2003-05-22 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders |
JP2002501033A (en) * | 1998-01-26 | 2002-01-15 | ユニバーシティー オブ マサチューセッツ | Biologically active hemagglutinin of Clostridium botulinum type A and its use |
US7780967B2 (en) * | 2000-02-08 | 2010-08-24 | Allergan, Inc. | Reduced toxicity Clostridial toxin pharmaceutical compositions |
US20040033241A1 (en) * | 2000-06-02 | 2004-02-19 | Allergan, Inc. | Controlled release botulinum toxin system |
AU2002320127A1 (en) * | 2001-06-21 | 2003-01-08 | Surromed, Inc. | Covalent coupling of botulinum toxin with polyethylene glycol |
-
2004
- 2004-10-28 GB GB0423950A patent/GB2426702A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB2426702A (en) | 2006-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL180380A0 (en) | Pharmaceutical composition containing botulinum neurotoxin | |
PT1776137E (en) | Pharmaceutical composition containing botulinum neurotoxin a2 | |
IL225848A0 (en) | Therapeutic composition with a botulinum neurotoxin | |
IL177480A0 (en) | Pharmaceutical composition | |
ZA200606154B (en) | Pharmaceutical composition comprising pimobendan | |
EP1871347A4 (en) | Pharmaceutical composition | |
EP1937255A4 (en) | Pharmaceutical composition | |
EP1862184A4 (en) | Pharmaceutical composition | |
EP1889613A4 (en) | Pharmaceutical composition comprising vitamin k | |
HU0401177D0 (en) | Pharmaceutical composition | |
GB0423952D0 (en) | Pharmaceutical composition containing botulinum neurotoxin | |
GB0417367D0 (en) | Pharmaceutical composition containing botulinum neurotoxin | |
GB2411355B (en) | Pharmaceutical composition | |
GB0423953D0 (en) | Pharmaceutical composition containing botulinum neurotoxin | |
ZA200701932B (en) | Pharmaceutical composition | |
GB0425255D0 (en) | Pharmaceutical composition | |
GB0423950D0 (en) | Pharmaceutical composition containing botulinum neurotoxin | |
GB0421288D0 (en) | Pharmaceutical composition containing botulinum neurotoxin | |
ZA200701931B (en) | Pharmaceutical composition | |
HUP0500813A2 (en) | Pharmaceutical composition containing violaceae extract | |
GB0421290D0 (en) | Pharmaceutical composition containing botulinum neurotoxin | |
HK1216998A1 (en) | Pharmaceutical compositions comprising botulinum neurotoxin | |
HUP0401176A2 (en) | Pharmaceutical composition having prpkinetic effect | |
ZA200808768B (en) | Pharmaceutical composition containing the NMB0606 protein | |
ZA200805355B (en) | Pharmaceutical compositions containing protein NMA0939 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |